CAR T-Cell Therapy Targeting GPRC5D Antigen Proves Effective in First Trial miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Buffalo, NY (PRWEB) September 28, 2022 A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute and Roswell Park Comprehensive Cancer Center report in a new study published today by the New England Journal of Medicine.
Veteran scientist to oversee new opportunities for scientific discovery Made noteworthy discoveries in tumor suppression, precision theraputics Will also continue as Chair of Molecular and Cellular Biology.